Thus, lncRNA ADAMTS9-AS1 can attenuate ferroptosis by targeting the miR-587/SLC7A11 axis in ovarian cancer cell lines, thereby providing a new therapeutic target for the treatment of these patients [120]. This evidence concerns the gene SLC7A11 and ovarian carcinoma.